VAXART, INC Gross Margin 2012-2026 | VXRT

Current and historical gross margin for VAXART, INC (VXRT) over the last 10 years. The current gross profit margin for VAXART, INC as of June 30, 2026 is %.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
VAXART, INC Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2026-06-30 $0.24B $0.24B 100.00%
2026-03-31 $0.26B $0.26B 100.00%
2025-12-31 $0.24B $0.24B 100.00%
2025-09-30 $0.15B $0.15B 100.00%
2025-06-30 $0.08B $0.08B 100.00%
2025-03-31 $0.05B $0.05B 100.00%
2024-12-31 $0.03B $0.03B 100.00%
2024-09-30 $0.02B $0.02B 100.00%
2024-06-30 $0.01B $0.01B 100.00%
2024-03-31 $0.01B $0.01B 100.00%
2023-12-31 $0.01B $0.01B 100.00%
2023-09-30 $0.00B $0.00B 100.00%
2022-12-31 $0.00B 0 0.00%
2022-03-31 $0.00B 0 0.00%
2021-12-31 $0.00B $0.00B 100.00%
2021-09-30 $0.00B $0.00B 100.00%
2021-06-30 $0.00B $0.00B 100.00%
2021-03-31 $0.00B $0.00B 100.00%
2020-12-31 $0.00B $0.00B 100.00%
2020-09-30 $0.01B $0.01B 100.00%
2020-06-30 $0.01B $0.01B 100.00%
2020-03-31 $0.01B $0.01B 100.00%
2019-12-31 $0.01B $0.01B 100.00%
2019-09-30 $0.01B $0.01B 100.00%
2019-06-30 $0.01B $0.01B 100.00%
2019-03-31 $0.01B $0.01B 100.00%
2018-12-31 $0.01B $0.01B 100.00%
2018-09-30 $0.01B $0.01B 100.00%
2018-06-30 $0.01B $0.01B 100.00%
2018-03-31 $0.01B $0.01B 100.00%
2017-12-31 $0.01B $0.01B 100.00%
2017-09-30 $0.01B $0.01B 100.00%
2017-06-30 $0.01B $0.01B 100.00%
2016-12-31 $0.01B $0.01B 100.00%
2016-09-30 $0.01B $0.01B 100.00%
2015-12-31 $0.01B $0.01B 100.00%
2015-09-30 $0.02B $0.02B 90.91%
2014-12-31 $0.05B $0.02B 46.67%
2014-09-30 $0.05B $0.02B 32.00%
2013-12-31 $0.04B $0.02B 38.64%
2013-09-30 $0.04B $0.01B 37.14%
2013-03-31 $0.03B $0.01B 46.15%
2012-12-31 $0.02B $0.01B 45.00%
2012-09-30 $0.01B $0.01B 41.67%
2012-06-30 $0.01B $0.01B 54.55%
2012-03-31 $0.01B $0.01B 57.14%
2011-12-31 $0.02B $0.01B 75.00%
2011-09-30 $0.02B $0.02B 83.33%
2011-06-30 $0.03B $0.03B 86.21%
2011-03-31 $0.03B $0.03B 86.67%
2010-12-31 $0.04B $0.03B 85.71%
2006-06-30 $0.06B $0.02B 32.26%
2006-03-31 $0.07B $0.02B 35.29%
2005-09-30 $0.08B $0.01B 15.38%
2005-06-30 $0.10B $0.03B 26.00%
2005-03-31 $0.12B $0.04B 33.61%
2004-12-31 $0.14B $0.06B 38.73%
2004-09-30 $0.19B $0.10B 51.61%
2004-06-30 $0.18B $0.09B 51.09%
2004-03-31 $0.17B $0.08B 49.12%
2003-12-31 $0.18B $0.08B 44.07%
2003-09-30 $0.19B $0.07B 37.97%
2003-06-30 $0.19B $0.07B 34.03%
2003-03-31 $0.21B $0.07B 31.88%
2002-12-31 $0.20B $0.06B 32.14%
2002-09-30 $0.19B $0.07B 34.72%
2002-06-30 $0.20B $0.07B 34.16%
2002-03-31 $0.22B $0.07B 32.41%
2001-12-31 $0.24B $0.07B 29.79%
2001-09-30 $0.25B $0.07B 28.86%
2001-06-30 $0.24B $0.06B 26.14%
2001-03-31 $0.23B $0.06B 26.07%
2000-12-31 $0.23B $0.06B 26.52%
2000-09-30 $0.22B $0.06B 26.46%
2000-06-30 $0.23B $0.07B 29.52%
2000-03-31 $0.23B $0.07B 31.17%
1999-12-31 $0.23B $0.07B 30.47%
1999-09-30 $0.24B $0.12B 48.12%
1999-06-30 $0.24B $0.11B 46.72%
1999-03-31 $0.24B $0.11B 46.09%
1998-12-31 $0.24B $0.11B 46.31%
1998-09-30 $0.24B $0.06B 24.48%
1998-06-30 $0.24B $0.05B 22.13%
1998-03-31 $0.23B $0.05B 21.12%
1997-12-31 $0.23B $0.05B 20.96%
1997-09-30 $0.23B $0.06B 23.61%
1997-06-30 $0.24B $0.06B 24.79%
1997-03-31 $0.24B $0.06B 24.37%
1996-12-31 $0.24B $0.06B 24.48%
1996-09-30 $0.23B $0.06B 24.35%
1996-06-30 $0.22B $0.06B 24.77%
1996-03-31 $0.21B $0.05B 24.88%
1995-12-31 $0.20B $0.05B 24.00%
1995-09-30 $0.19B $0.04B 22.22%
1995-06-30 $0.18B $0.04B 21.31%
1995-03-31 $0.18B $0.04B 19.89%
1994-12-31 $0.17B $0.03B 19.88%
1994-09-30 $0.15B $0.03B 19.74%
1994-06-30 $0.14B $0.03B 19.12%
1994-03-31 $0.12B $0.02B 19.66%
1993-12-31 $0.10B $0.02B 19.42%
1993-09-30 $0.10B $0.04B 37.89%
1993-06-30 $0.09B $0.05B 59.55%
1993-03-31 $0.09B $0.05B 59.30%
1992-12-31 $0.08B $0.05B 60.98%
1992-09-30 $0.08B $0.03B 39.74%
1992-06-30 $0.07B $0.01B 15.07%
1992-03-31 $0.07B $0.01B 14.49%
1991-12-31 $0.07B $0.01B 13.24%
1991-09-30 $0.07B $0.01B 11.94%
1991-06-30 $0.07B $0.01B 13.24%
1991-03-31 $0.07B $0.01B 14.08%
1990-12-31 $0.07B $0.01B 13.89%
1990-09-30 $0.05B $-0.01B -12.96%
1990-06-30 $0.05B $-0.01B -15.69%
1990-03-31 $0.05B $-0.01B -21.74%
1989-12-31 $0.04B $-0.01B -26.19%
1989-09-30 $0.04B $0.01B 30.00%
1989-06-30 $0.05B $0.00B 7.84%
1989-03-31 $0.05B $0.00B 8.16%
1988-12-31 $0.05B $0.00B 8.51%
1988-09-30 $0.06B $0.00B -4.92%
1988-06-30 $0.05B $0.00B 8.70%
1988-03-31 $0.05B $0.00B 8.89%
1987-12-31 $0.04B $0.00B 9.09%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.117B $0.237B
Vaxart, Inc. is a clinical-stage company developing a range of oral recombinant vaccines based on its proprietary delivery platform. The company's vaccines are administered using convenient room temperature-stable tablets that can be stored and shipped without refrigeration and eliminate risk of needle-stick injury. Its development programs are oral tablet vaccines designed to protect against norovirus, seasonal influenza and respiratory syncytial virus, as well as a therapeutic vaccine for human papillomavirus. Vaxart, Inc., formerly known as Aviragen Therapeutics, is based in South San Francisco, United States.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $68.396B 22.59
Takeda Pharmaceutical (TAK) Japan $59.919B 11.13
UCB SA (UCBJY) Belgium $45.739B 0.00
Otsuka Holdings, - (OTSKY) Japan $39.680B 14.84
BeOne Medicines - (ONC) Switzerland $38.041B 61.00
Sandoz Group AG (SDZNY) Switzerland $35.464B 0.00
Daiichi Sankyo, - (DSNKY) Japan $34.072B 21.27
Zoetis (ZTS) United States $30.343B 11.16
Astellas Pharma (ALPMY) Japan $26.892B 8.90
United Therapeutics (UTHR) United States $21.460B 17.90
Merck (MKKGY) Germany $19.487B 15.54
Shionogi (SGIOY) Japan $15.947B 9.37
IPSEN (IPSEY) France $15.395B 0.00
Neurocrine Biosciences (NBIX) United States $15.249B 20.72
Summit Therapeutics (SMMT) United States $13.881B 0.00
Orion OYJ (ORINY) Finland $12.984B 18.93
Madrigal Pharmaceuticals (MDGL) United States $12.089B 0.00
Corcept Therapeutics (CORT) United States $11.979B 263.86
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.965B 15.26
Crinetics Pharmaceuticals (CRNX) United States $9.013B 0.00
Eisai (ESAIY) $8.924B 0.00
Ionis Pharmaceuticals (IONS) United States $7.852B 0.00
Ono Pharmaceutical (OPHLF) Japan $7.049B 13.27
Stevanato Group S.p.A (STVN) Italy $6.523B 32.64
Centessa Pharmaceuticals (CNTA) United Kingdom $6.267B 0.00
Oruka Therapeutics (ORKA) United States $6.105B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $5.317B 19.36
Grifols, S.A (GRFS) Spain $5.009B 0.00
Definium Therapeutics (DFTX) United States $4.947B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.923B 0.00
Relay Therapeutics (RLAY) United States $4.157B 0.00
Indivior Pharmaceuticals (INDV) United States $4.039B 9.38
Enliven Therapeutics (ELVN) United States $3.910B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.855B 11.93
Amylyx Pharmaceuticals (AMLX) United States $3.694B 0.00
Dyne Therapeutics (DYN) United States $3.343B 0.00
Hypermarcas (HYPMY) Brazil $3.203B 9.10
Soleno Therapeutics (SLNO) United States $2.717B 228.83
NewAmsterdam Pharma (NAMS) Netherlands $2.529B 0.00
Guardian Pharmacy Services (GRDN) United States $2.390B 45.28
Nektar Therapeutics (NKTR) United States $2.275B 0.00
Ocular Therapeutix (OCUL) United States $2.238B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.146B 15.81
Avadel Pharmaceuticals (AVDL) Ireland $2.113B 0.00
BioCryst Pharmaceuticals (BCRX) United States $2.085B 5.63
Xencor (XNCR) United States $1.766B 0.00
KARDIGAN INC (KARD) United States $1.735B 0.00
Xeris Biopharma Holdings (XERS) United States $1.366B 107.00
Harrow (HROW) United States $1.269B 0.00
Seaport Therapeutics (SPTX) United States $1.229B 0.00
Aktis Oncology (AKTS) United States $1.204B 0.00
Cronos Group (CRON) Canada $1.179B 29.09
Bioventus (BVS) United States $1.093B 17.10
Savara (SVRA) United States $1.081B 0.00
KalVista Pharmaceuticals (KALV) United States $0.993B 0.00
Cybin (HELP) Canada $0.992B 0.00
Theravance Biopharma (TBPH) United States $0.885B 0.00
Avalo Therapeutics (AVTX) United States $0.862B 0.00
Ardelyx (ARDX) United States $0.847B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.821B 11.32
Esperion Therapeutics (ESPR) United States $0.819B 0.00
Aclaris Therapeutics (ACRS) United States $0.773B 0.00
Achieve Life Sciences (ACHV) Canada $0.753B 0.00
4D Molecular Therapeutics (FDMT) United States $0.753B 0.00
Silence Therapeutics (SLN) United Kingdom $0.750B 0.00
Apnimed (APMD) $0.711B 0.00
Collegium Pharmaceutical (COLL) United States $0.711B 3.13
Zevra Therapeutics (ZVRA) United States $0.692B 7.37
Ironwood Pharmaceuticals (IRWD) United States $0.671B 5.21
OmniAb (OABI) United States $0.630B 0.00
Altimmune (ALT) United States $0.628B 0.00
Aquestive Therapeutics (AQST) United States $0.604B 0.00
Evotec AG (EVO) Germany $0.580B 0.00
ProKidney (PROK) United States $0.526B 0.00
Indaptus Therapeutics (INDP) United States $0.485B 0.00
Relmada Therapeutics (RLMD) United States $0.474B 0.00
ARS Pharmaceuticals (SPRY) United States $0.423B 0.00
Larimar Therapeutics (LRMR) United States $0.406B 0.00
Prelude Therapeutics (PRLD) United States $0.361B 0.00
Century Therapeutics (IPSC) United States $0.359B 0.00
Lexeo Therapeutics (LXEO) United States $0.339B 0.00
Inhibikase Therapeutics (IKT) United States $0.322B 0.00
Avita Medical (RCEL) United States $0.314B 0.00
Pyxis Oncology (PYXS) United States $0.278B 0.00
USANA Health Sciences (USNA) United States $0.275B 15.05
Elite Pharmaceuticals (ELTP) United States $0.268B 12.44
Lyell Immunopharma (LYEL) United States $0.267B 0.00
Akebia Therapeutics (AKBA) United States $0.250B 0.00
Galectin Therapeutics (GALT) United States $0.246B 0.00
Nature's Sunshine Products (NATR) United States $0.230B 11.17
AleAnna (ANNA) United States $0.226B 17.84
Protara Therapeutics (TARA) United States $0.222B 0.00
Cardiol Therapeutics (CRDL) Canada $0.215B 0.00
Siga Technologies (SIGA) United States $0.214B 0.00
Journey Medical (DERM) United States $0.208B 0.00
Profound Medical (PROF) Canada $0.208B 0.00
Korro Bio (KRRO) United States $0.207B 0.00
Surrozen (SRZN) United States $0.206B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.199B 0.00
Organogenesis (ORGO) United States $0.188B 0.00
Minerva Neurosciences (NERV) United States $0.183B 0.00
MediWound (MDWD) Israel $0.173B 0.00
Atrium Therapeutics (RNA) United States $0.173B 0.00
NRx Pharmaceuticals (NRXP) United States $0.147B 0.00
Innate Pharma SA (IPHYF) France $0.138B 0.00
Unicycive Therapeutics (UNCY) United States $0.131B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.129B 0.00
Assertio Holdings (ASRT) United States $0.116B 0.00
Rafael Holdings (RFL) United States $0.111B 0.00
Vivani Medical (VANI) United States $0.111B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.103B 0.00
Cassava Sciences (SAVA) United States $0.101B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.099B 0.00
PolyPid (PYPD) Israel $0.098B 0.00
HST Global (HSTC) United States $0.092B 0.00
ElectroCore (ECOR) United States $0.091B 0.00
Fractyl Health (GUTS) United States $0.090B 0.00
Nutriband (NTRB) United States $0.083B 0.00
Aldeyra Therapeutics (ALDX) United States $0.083B 0.00
Telomir Pharmaceuticals (TELO) United States $0.080B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.079B 0.00
Acrivon Therapeutics (ACRV) United States $0.078B 0.00
Gain Therapeutics (GANX) United States $0.075B 0.00
PMV Pharmaceuticals (PMVP) United States $0.073B 0.00
Champions Oncology (CSBR) United States $0.066B 0.00
Talphera (TLPH) United States $0.062B 0.00
Nuo Therapeutics (AURX) $0.061B 0.00
Heron Therapeutics (HRTX) United States $0.060B 0.00
Dominari Holdings (DOMH) United States $0.053B 0.00
Veraxa Biotech AG (VRXA) United States $0.048B 0.00
SCYNEXIS (SCYX) United States $0.044B 0.00
Incannex Healthcare (IXHL) Australia $0.041B 0.00
FibroGen (FGEN) United States $0.039B 0.00
Lite Strategy (LITS) United States $0.037B 0.00
Mural Oncology (MURA) Ireland $0.035B 0.00
Karyopharm Therapeutics (KPTI) United States $0.035B 0.00
Context Therapeutics (CNTX) United States $0.033B 0.00
Optimi Health (OPTH) Canada $0.029B 0.00
Cosmos Health (COSM) United States $0.028B 0.00
TransCode Therapeutics (RNAZ) United States $0.027B 0.00
Plus Therapeutics (PSTV) United States $0.027B 0.00
TherapeuticsMD (TXMD) United States $0.025B 0.00
Universe Pharmaceuticals INC (UPC) China $0.022B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.020B 0.00
VYNE Therapeutics (VYNE) United States $0.019B 0.00
Lipocine (LPCN) United States $0.018B 0.00
Klotho Neurosciences (KLTO) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Enlivex (ENLV) Israel $0.015B 0.00
Citius Pharmaceuticals (CTXR) United States $0.015B 0.00
BioVie (BIVI) United States $0.015B 0.00
Iterum Therapeutics (ITRM) Ireland $0.015B 0.00
Vyome Holdings (HIND) United States $0.014B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.014B 0.00
Scienture Holdings (SCNX) United States $0.014B 0.00
Tempest Therapeutics (TPST) United States $0.012B 0.00
Natural Alternatives (NAII) United States $0.012B 0.00
BioLineRx (BLRX) Israel $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.012B 0.00
CASI Pharmaceuticals (CASI) China $0.010B 0.00
Xenetic Biosciences (XBIO) United States $0.010B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Wellgistics Health (WGRX) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Inotiv (NOTV) United States $0.008B 0.00
Biomerica (BMRA) United States $0.007B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.007B 0.00
Ernexa Therapeutics (ERNA) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.005B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.005B 0.00
Liminatus Pharma (LIMN) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Niki BioSolutions (NIKI) United Kingdom $0.004B 0.00
Nuvilex (PMCB) United States $0.004B 0.00
Addex Therapeutics (ADXN) Switzerland $0.004B 0.00
Galmed Pharmaceuticals (EOCN) Israel $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Jupiter Neurosciences (JUNS) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Vivos Therapeutics (VVOS) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Jaguar Animal Health (JAGX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Clearmind Medicine (CMND) Canada $0.001B 0.00
PainReform (PRFX) Israel $0.001B 0.00
CDT Equity (CDT) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00